Skip to main content

Compounded medication
Dispensed by a licensed 503A compounding pharmacy
Prescribed only when clinically appropriate

TreatmentsMicrodosingMicrodose Core — Semaglutide
Microdose Core semaglutide compounded injection vial503A · CompoundedIllustration only. Actual medication will vary.

Microdosing · Low-dose semaglutide blend

Microdose Core —
Semaglutide

A low-dose weekly semaglutide injection paired with lipotropic support, individually formulated for metabolic maintenance and optimization at sub-therapeutic weight-loss dosing.

503A · CompoundedPhysician-reviewedU.S. pharmacy

Your Plan Options

Semaglutide + B12 / Methionine / Inositol / Choline

4-week plan · weekly injection

$179 /4 wk

Semaglutide + B12 / Methionine / Inositol / Choline

12-week plan · weekly injection

$507 /12 wk

Semaglutide + L-Carnitine

4-week plan · weekly injection

$179 /4 wk

Semaglutide + L-Carnitine

12-week plan · weekly injection

$507 /12 wk

Begin your consultation

No charge until a provider prescribes. Prescription required.

Clinical information

What this is, in plain language.

Microdose Core — Semaglutide pairs a low dose of semaglutide (GLP-1) with lipotropic and metabolic co-factors — either a B12 / methionine / inositol / choline chloride blend or L-carnitine. It is prepared by a licensed 503A compounding pharmacy and dispensed only when a licensed provider determines it is clinically appropriate. The specific formulation is selected under clinical guidance.

Active ingredients

Semaglutide, with either B12, methionine, inositol and choline chloride, or L-carnitine.

Mechanism

Low-dose GLP-1 receptor activation combined with lipotropic co-factors (methionine, inositol, choline) or L-carnitine.

Administration

Once-weekly subcutaneous injection at individualized low doses.

Who it is for

Patients in a maintenance phase or seeking metabolic benefits at sub-therapeutic semaglutide doses.

Common effects

Generally well-tolerated at low doses. Mild GI effects and injection-site soreness possible. Discuss risks with your provider.

Important safety & compliance information

Compounded semaglutide microdose blend is not FDA-approved. It is prepared by a licensed 503A compounding pharmacy and is descriptive only — it is not a branded drug. Product imagery shown here is illustration only; actual medication is dispensed in a pharmacy-labeled container and will vary in appearance. A prescription is required and is issued only when a licensed provider determines treatment is clinically appropriate. This page is not medical advice. Discuss benefits, risks and side effects with your provider.